250 related articles for article (PubMed ID: 22850318)
1. The effect of water loading on the urinary ratio of cortisone to cortisol in healthy subjects and a new approach to the evaluation of the ratio as an index for in vivo human 11β-hydroxysteroid dehydrogenase 2 activity.
Yokokawa A; Takasaka T; Shibasaki H; Kasuya Y; Kawashima S; Yamada A; Furuta T
Steroids; 2012 Oct; 77(12):1291-7. PubMed ID: 22850318
[TBL] [Abstract][Full Text] [Related]
2. Urinary free cortisone, but not cortisol, is associated with urine volume in severe obesity.
Müssig K; Remer T; Fritsche A; Häring HU; Maser-Gluth C
Steroids; 2009 Sep; 74(9):742-5. PubMed ID: 19541001
[TBL] [Abstract][Full Text] [Related]
3. Use of 11alpha-deuterium labeled cortisol as a tracer for assessing reduced 11beta-HSD2 activity in vivo following glycyrrhetinic acid ingestion in a human subject.
Kasuya Y; Yokokawa A; Takashima S; Shibasaki H; Furuta T
Steroids; 2005 Feb; 70(2):117-25. PubMed ID: 15631868
[TBL] [Abstract][Full Text] [Related]
4. Urinary free cortisone and the assessment of 11 beta-hydroxysteroid dehydrogenase activity in man.
Palermo M; Shackleton CH; Mantero F; Stewart PM
Clin Endocrinol (Oxf); 1996 Nov; 45(5):605-11. PubMed ID: 8977758
[TBL] [Abstract][Full Text] [Related]
5. Expression of renal 11beta-hydroxysteroid dehydrogenase type 2 is decreased in patients with impaired renal function.
Quinkler M; Zehnder D; Lepenies J; Petrelli MD; Moore JS; Hughes SV; Cockwell P; Hewison M; Stewart PM
Eur J Endocrinol; 2005 Aug; 153(2):291-9. PubMed ID: 16061836
[TBL] [Abstract][Full Text] [Related]
6. 11beta-hydroxysteroid dehydrogenase 2 activity is elevated in severe obesity and negatively associated with insulin sensitivity.
Müssig K; Remer T; Haupt A; Gallwitz B; Fritsche A; Häring HU; Maser-Gluth C
Obesity (Silver Spring); 2008 Jun; 16(6):1256-60. PubMed ID: 18421276
[TBL] [Abstract][Full Text] [Related]
7. Glucocorticoid Metabolism in Hypertensive Disorders of Pregnancy: Analysis of Plasma and Urinary Cortisol and Cortisone.
Kosicka K; Siemiątkowska A; Krzyścin M; Bręborowicz GH; Resztak M; Majchrzak-Celińska A; Chuchracki M; Główka FK
PLoS One; 2015; 10(12):e0144343. PubMed ID: 26637176
[TBL] [Abstract][Full Text] [Related]
8. Administration of glycyrrhetinic acid: significant correlation between serum levels and the cortisol/cortisone-ratio in serum and urine.
Heilmann P; Heide J; Hundertmark S; Schöneshöfer M
Exp Clin Endocrinol Diabetes; 1999; 107(6):370-8. PubMed ID: 10543414
[TBL] [Abstract][Full Text] [Related]
9. Congenital deficiency of 11beta-hydroxysteroid dehydrogenase (apparent mineralocorticoid excess syndrome): diagnostic value of urinary free cortisol and cortisone.
Palermo M; Delitala G; Mantero F; Stewart PM; Shackleton CH
J Endocrinol Invest; 2001 Jan; 24(1):17-23. PubMed ID: 11227727
[TBL] [Abstract][Full Text] [Related]
10. Role of ketoconazole treatment in urinary-free cortisol-to-cortisone and tetrahydrocortisol-to-tetrahydrocortisone ratios in nonectopic Cushing's syndrome.
Stiefel P; García-Morillo JS; Jimenez L; Pamies E; Miranda ML; Carneado J; Villar J; Leal-Cerro A
Endocrine; 2002 Aug; 18(3):279-84. PubMed ID: 12450320
[TBL] [Abstract][Full Text] [Related]
11. Cortisol metabolism in depressed patients and healthy controls.
Römer B; Lewicka S; Kopf D; Lederbogen F; Hamann B; Gilles M; Schilling C; Onken V; Frankhauser P; Deuschle M
Neuroendocrinology; 2009; 90(3):301-6. PubMed ID: 19713693
[TBL] [Abstract][Full Text] [Related]
12. The activity of 11β-hydroxysteroid dehydrogenase type 2 enzyme and cortisol secretion in patients with adrenal incidentalomas.
Morelli V; Polledri E; Mercadante R; Zhukouskaya V; Palmieri S; Beck-Peccoz P; Spada A; Fustinoni S; Chiodini I
Endocrine; 2016 Sep; 53(3):809-15. PubMed ID: 26438395
[TBL] [Abstract][Full Text] [Related]
13. Daily urinary free cortisol and cortisone excretion is associated with urine volume in healthy children.
Shi L; Maser-Gluth C; Remer T
Steroids; 2008 Dec; 73(14):1446-51. PubMed ID: 18762206
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive study of urinary cortisol metabolites in hyperthyroid and hypothyroid patients.
Hoshiro M; Ohno Y; Masaki H; Iwase H; Aoki N
Clin Endocrinol (Oxf); 2006 Jan; 64(1):37-45. PubMed ID: 16402926
[TBL] [Abstract][Full Text] [Related]
15. In vivo activity of 11beta-hydroxysteroid dehydrogenase type 1 and free fatty acid-induced insulin resistance.
Mai K; Kullmann V; Bobbert T; Maser-Gluth C; Möhlig M; Bähr V; Pfeiffer AF; Spranger J; Diederich S
Clin Endocrinol (Oxf); 2005 Oct; 63(4):442-9. PubMed ID: 16181237
[TBL] [Abstract][Full Text] [Related]
16. In vivo 11beta-HSD-2 activity: variability, salt-sensitivity, and effect of licorice.
Ferrari P; Sansonnens A; Dick B; Frey FJ
Hypertension; 2001 Dec; 38(6):1330-6. PubMed ID: 11751713
[TBL] [Abstract][Full Text] [Related]
17. Exaggerated adrenarche and altered cortisol metabolism in Type 1 diabetic children.
Remer T; Maser-Gluth C; Boye KR; Hartmann MF; Heinze E; Wudy SA
Steroids; 2006 Jul; 71(7):591-8. PubMed ID: 16616286
[TBL] [Abstract][Full Text] [Related]
18. Age-related changes in 11β-hydroxysteroid dehydrogenase type 2 activity in normotensive subjects.
Campino C; Martinez-Aguayo A; Baudrand R; Carvajal CA; Aglony M; Garcia H; Padilla O; Kalergis AM; Fardella CE
Am J Hypertens; 2013 Apr; 26(4):481-7. PubMed ID: 23443726
[TBL] [Abstract][Full Text] [Related]
19. Glycyrrhetinic acid attenuates vascular smooth muscle vasodilatory function in healthy humans.
Sobieszczyk P; Borlaug BA; Gornik HL; Knauft WD; Beckman JA
Clin Sci (Lond); 2010 Aug; 119(10):437-42. PubMed ID: 20515440
[TBL] [Abstract][Full Text] [Related]
20. 11-Beta Dehydrogenase Type 2 Activity Is Not Reduced in Treatment Resistant Hypertension.
Ghazi L; Dudenbostel T; Hachem ME; Siddiqui M; Lin CP; Oparil S; Calhoun DA
Am J Hypertens; 2017 May; 30(5):518-523. PubMed ID: 28180242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
